Visual Capitalist April 1, 2020
Nick Routley

As the number of confirmed COVID-19 cases continues to skyrocket, healthcare researchers around the world are working tirelessly to discover new life-saving medical innovations.

The projects these companies are working on can be organized into three distinct groups:

  1. Diagnostics: Quickly and effectively detecting the disease in the first place
  2. Treatments: Alleviating symptoms so people who have disease experience milder symptoms, and lowering the overall mortality rate
  3. Vaccines: Preventing transmission by making the population immune to COVID-19

Today’s graphics provide an in-depth look at who’s in the innovation race to defeat the virus, and they come to us courtesy of Artis Ventures, a venture capital firm focused on...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Provider, Technology, Trends
It's Not Just Congress. There's Plenty of State-Level Action on PBMs, Drug Costs and Prices | AMCP 2024
On the Front Lines: Pharmacists' Role in Combating America's Opioid Epidemic
Ultimovacs lays off 40% in wake of cancer vaccine's phase 2 fail
How to Include Patients When Measuring Value | AMCP 2024
Pfizer focuses on long COVID in latest 'Dear Scientist' video

Share This Article